newsfilter
← Latest News
GlobeNewswire·

NexImmune Announces 1-for-25 Reverse Stock Split

GAITHERSBURG, Md., Oct. 18, 2023 (GLOBE NEWSWIRE) -- NexImmune, Inc. (NASDAQ:NEXI) (the "Company") a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response